{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:40:09Z","timestamp":1792791609379,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A novel acquired coagulopathy characterized by severe procoagulant imbalance is common and associated with the clinical severity in COVID-19 patients. To elucidate the underlying mechanisms of coagulation activation in COVID-19 patients. Symptomatic COVID-19 patients were consecutively enrolled and stratified into 3 groups based on the intensity of care. Markers of intrinsic (FXIa, FXIIa) and extrinsic (FVIIa) pathway activation and of fibrinolysis (plasminogen and relative activator and inhibitors),\n                    <jats:sc>d<\/jats:sc>\n                    -dimer, fibrin monomer (FM), fibrin degradation products (FDP), and C1 inhibitor were tested. A total of 111 patients were enrolled, 26 in the low, 42 in the intermediate, and 43 in the high intensity of care group. Median\n                    <jats:sc>d<\/jats:sc>\n                    -dimer, FDP, and FM plasma levels were higher in COVID-19 patients than normal ranges, with a gradient of increase across the three intensity care units; the fibrinolytic pathway parameters were in the normal range. The median plasma levels of FVIIa were lower in COVID-19 patients (27.5\u00a0mU\/mL) than the reference range while the median plasma levels of FXIIa and FXIa were higher (11.2 and 11.3\u00a0mU\/mL), with a gradient of increase across the three intensity care units for FXIIa. C1 inhibitor plasma levels were above the normal range in all the 3 COVID-19 patient groups. 32 patients (29%) developed a venous thrombosis. Our study suggested a prevalent activation of the contact pathway over the extrinsic pathway of the coagulation cascade in COVID-19 patients, which is proportional to the clinical severity of the infection, opening the possibility for targeted anticoagulant therapies.\n                  <\/jats:p>","DOI":"10.1007\/s11739-025-04191-z","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:34:19Z","timestamp":1762626859000},"page":"2699-2709","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Involvement of the contact pathway in COVID-19 coagulopathy"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-145X","authenticated-orcid":false,"given":"Marco","family":"Capecchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Novembrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Abbattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Boscolo-Anzoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Griffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grovetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Grasselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"key":"4191_CR1","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ (2020) Severe Covid-19. N Engl J Med 383:2451\u20132460","journal-title":"N Engl J Med"},{"key":"4191_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA J Am Med Assoc 323:1239\u20131242","journal-title":"JAMA J Am Med Assoc"},{"key":"4191_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/23744235.2020.1859131","volume":"53","author":"M Abbattista","year":"2021","unstructured":"Abbattista M, Ciavarella A, Capecchi M et al (2021) Risk factors for mortality in hospitalized patients with COVID-19: a study in Milan, Italy. Infect Dis 53:226\u2013229","journal-title":"Infect Dis"},{"key":"4191_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M20-2003","volume":"173","author":"D Wichmann","year":"2020","unstructured":"Wichmann D, Sperhake JP, L\u00fctgehetmann M et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med 173:268\u2013277","journal-title":"Ann Intern Med"},{"key":"4191_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41586-021-03767-x","volume":"600","author":"COVID-19 Host Genetics Initiative","year":"2021","unstructured":"COVID-19 Host Genetics Initiative (2021) Mapping the human genetic architecture of COVID-19. Nature 600:472\u2013477","journal-title":"Nature"},{"key":"4191_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152386","author":"T Nakanishi","year":"2021","unstructured":"Nakanishi T, Pigazzini S, Degenhardt F et al (2021) Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI152386","journal-title":"J Clin Investig"},{"key":"4191_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147","journal-title":"Thromb Res"},{"key":"4191_CR8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/jth.14929","volume":"18","author":"AC Spyropoulos","year":"2020","unstructured":"Spyropoulos AC, Levy JH, Ageno W et al (2020) Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 18:1859\u20131865","journal-title":"J Thromb Haemost"},{"key":"4191_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1182\/blood.2020006520","volume":"136","author":"H Al-Samkari","year":"2020","unstructured":"Al-Samkari H, Karp Leaf RS, Dzik WH et al (2020) COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood 136:489\u2013500","journal-title":"Blood"},{"key":"4191_CR10","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054\u20131062","journal-title":"Lancet"},{"key":"4191_CR11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3324\/haematol.2020.262634","volume":"106","author":"F Peyvandi","year":"2020","unstructured":"Peyvandi F, Artoni A, Novembrino C et al (2020) Hemostatic alterations in COVID-19. Haematologica 106:1472\u20131475","journal-title":"Haematologica"},{"key":"4191_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1042\/CS20220208","volume":"136","author":"PA Klavina","year":"2022","unstructured":"Klavina PA, Leon G, Curtis AM, Preston RJS (2022) Dysregulated haemostasis in thrombo-inflammatory disease. Clin Sci 136:1809\u20131829","journal-title":"Clin Sci"},{"key":"4191_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s11739-020-02432-x","volume":"15","author":"M Marietta","year":"2020","unstructured":"Marietta M, Coluccio V, Luppi M (2020) COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 15:1375\u20131387","journal-title":"Intern Emerg Med"},{"key":"4191_CR14","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1182\/bloodadvances.2021004816","volume":"6","author":"M Wygrecka","year":"2022","unstructured":"Wygrecka M, Birnhuber A, Seeliger B et al (2022) Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv 6:1074\u20131087","journal-title":"Blood Adv"},{"key":"4191_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jinf.2020.11.041","volume":"82","author":"E Falcinelli","year":"2021","unstructured":"Falcinelli E, Petito E, Becattini C et al (2021) Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients. J Infect 82:186\u2013230","journal-title":"J Infect"},{"key":"4191_CR16","doi-asserted-by":"publisher","first-page":"089","DOI":"10.1055\/s-0039-1694995","volume":"46","author":"T Iba","year":"2020","unstructured":"Iba T, Levi M, Levy JH (2020) Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost 46:089\u2013095","journal-title":"Semin Thromb Hemost"},{"key":"4191_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/jmv.23354","volume":"84","author":"M Goeijenbier","year":"2012","unstructured":"Goeijenbier M, van Wissen M, van de Weg C et al (2012) Viral infections and mechanisms of thrombosis and bleeding. J Med Virol 84:1680\u20131696","journal-title":"J Med Virol"},{"key":"4191_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1182\/blood.2021010685","volume":"138","author":"J Wang","year":"2021","unstructured":"Wang J, Pendurthi UR, Yi G, Rao LVM (2021) SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase. Blood 138:344\u2013349","journal-title":"Blood"},{"key":"4191_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Yalavarthi S, Shi H et al (2020) Neutrophil extracellular traps in COVID-19. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.138999","journal-title":"JCI Insight"},{"key":"4191_CR20","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","volume":"58","author":"M Leppkes","year":"2020","unstructured":"Leppkes M, Knopf J, Naschberger E et al (2020) Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine 58:102925","journal-title":"EBioMedicine"},{"key":"4191_CR21","doi-asserted-by":"publisher","first-page":"103382","DOI":"10.1016\/j.ebiom.2021.103382","volume":"67","author":"H Englert","year":"2021","unstructured":"Englert H, Rangaswamy C, Deppermann C et al (2021) Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation. EBioMedicine 67:103382","journal-title":"EBioMedicine"},{"key":"4191_CR22","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2017.170902","author":"O Kumano","year":"2018","unstructured":"Kumano O, Ieko M, Komiyama Y et al (2018) Basic evaluation of the newly developed \u2018Lias Auto P-FDP\u2019 assay and the influence of plasmin-\u03b12 plasmin inhibitor complex values on discrepancy in the comparison with \u2018Lias Auto D-Dimer Neo\u2019 assay. Clin Lab. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170902","journal-title":"Clin Lab"},{"key":"4191_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.transci.2016.12.029","volume":"56","author":"J Amiral","year":"2017","unstructured":"Amiral J, Dunois C, Amiral C, Seghatchian J (2017) The various assays for measuring activity states of factor VIIa in plasma and therapeutic products: diagnostic value and analytical usefulness in various pathophysiological states. Transfus Apher Sci 56:91\u201397","journal-title":"Transfus Apher Sci"},{"key":"4191_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000440824","volume":"42","author":"AE Oviedo","year":"2015","unstructured":"Oviedo AE, Bernardi ME, Guglielmone HA, Vitali MS (2015) Absence of in vitro procoagulant activity in immunoglobulin preparations due to activated coagulation factors. Transfus Med Hemother 42:397\u2013402","journal-title":"Transfus Med Hemother"},{"key":"4191_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1530\/EJE-16-0835","volume":"176","author":"N Kim","year":"2017","unstructured":"Kim N, Gu J-Y, Yoo HJ et al (2017) Contact system activation and high thrombin generation in hyperthyroidism. Eur J Endocrinol 176:583\u2013589","journal-title":"Eur J Endocrinol"},{"key":"4191_CR26","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","volume":"180","author":"P Sinha","year":"2020","unstructured":"Sinha P, Matthay MA, Calfee CS (2020) Is a \u201cCytokine Storm\u201d relevant to COVID-19? JAMA Intern Med 180:1152","journal-title":"JAMA Intern Med"},{"key":"4191_CR27","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1182\/bloodadvances.2021006620","volume":"6","author":"MW Henderson","year":"2022","unstructured":"Henderson MW, Lima F, Moraes CRP et al (2022) Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19. Blood Adv 6:3367\u20133377","journal-title":"Blood Adv"},{"key":"4191_CR28","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1161\/CIRCULATIONAHA.120.050656","volume":"142","author":"MH Busch","year":"2020","unstructured":"Busch MH, Timmermans SAMEG, Nagy M et al (2020) Neutrophils and contact activation of coagulation as potential drivers of COVID-19. Circulation 142:1787\u20131790","journal-title":"Circulation"},{"key":"4191_CR29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3324\/haematol.2022.281693","volume":"108","author":"MH Busch","year":"2022","unstructured":"Busch MH, Timmermans SAMEG, Van Kuijk SMJ et al (2022) Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19. Haematologica 108:1417\u20131422","journal-title":"Haematologica"},{"key":"4191_CR30","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD (2020) Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19. N Engl J Med 382:1653\u20131659","journal-title":"N Engl J Med"},{"key":"4191_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1182\/bloodadvances.2020003308","volume":"5","author":"C Guervilly","year":"2021","unstructured":"Guervilly C, Bonifay A, Burtey S et al (2021) Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv 5:628\u2013634","journal-title":"Blood Adv"},{"key":"4191_CR32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","volume":"41","author":"A Rosell","year":"2021","unstructured":"Rosell A, Havervall S, von Meijenfeldt F et al (2021) Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality\u2014brief report. Arterioscler Thromb Vasc Biol 41:878\u2013882","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4191_CR33","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.eclinm.2021.101069","volume":"39","author":"IMB Francischetti","year":"2021","unstructured":"Francischetti IMB, Toomer K, Zhang Y et al (2021) Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection. EClinicalMedicine 39:101069","journal-title":"EClinicalMedicine"},{"key":"4191_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jth.13235","volume":"14","author":"AT Long","year":"2016","unstructured":"Long AT, Kenne E, Jung R, Fuchs TA, Renn\u00e9 T (2016) Contact system revisited: an interface between inflammation, coagulation, and innate immunity. J Thromb Haemost 14:427\u2013437","journal-title":"J Thromb Haemost"},{"key":"4191_CR35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00001721-200106000-00002","volume":"12","author":"B Woodhams","year":"2001","unstructured":"Woodhams B, Girardot O, Blanco M-J, Colesse G, Gourmelin Y (2001) Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 12:229\u2013236","journal-title":"Blood Coagul Fibrinolysis"},{"key":"4191_CR36","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood.2022017074","volume":"141","author":"EM Sparkenbaugh","year":"2023","unstructured":"Sparkenbaugh EM, Henderson MW, Miller-Awe M et al (2023) Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease. Blood 141:1871\u20131883","journal-title":"Blood"},{"key":"4191_CR37","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.jtha.2023.06.009","volume":"21","author":"FTM Bosch","year":"2023","unstructured":"Bosch FTM, Campello E, Mulder FI et al (2023) Contact system and intrinsic pathway activation in patients with advanced pancreatic cancer: a prospective cohort study. J Thromb Haemost 21:2863\u20132872","journal-title":"J Thromb Haemost"},{"key":"4191_CR38","doi-asserted-by":"publisher","first-page":"119166","DOI":"10.1016\/j.bbamcr.2021.119166","volume":"1869","author":"RK Mailer","year":"2022","unstructured":"Mailer RK, Rangaswamy C, Konrath S, Emsley J, Renn\u00e9 T (2022) An update on factor XII-driven vascular inflammation. Biochim Biophys Acta Mol Cell Res 1869:119166","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4191_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.thromres.2011.11.051","volume":"129","author":"R He","year":"2012","unstructured":"He R, Chen D, He S (2012) Factor XI: hemostasis, thrombosis, and antithrombosis. Thromb Res 129:541\u2013550","journal-title":"Thromb Res"},{"key":"4191_CR40","first-page":"2390","volume":"141","author":"SP Grover","year":"2023","unstructured":"Grover SP, Kawano T, Wan J et al (2023) C1 inhibitor deficiency enhances contact pathway mediated activation of coagulation and venous thrombosis. Blood 141:2390\u20132401","journal-title":"Blood"},{"key":"4191_CR41","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/jth.15660","volume":"20","author":"S Kelliher","year":"2022","unstructured":"Kelliher S, Weiss L, Cullivan S et al (2022) Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J Thromb Haemost 20:1008\u20131014","journal-title":"J Thromb Haemost"},{"key":"4191_CR42","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jha2.654","volume":"4","author":"KH Toomer","year":"2023","unstructured":"Toomer KH, Gerber GF, Zhang Y et al (2023) SARS-CoV-2 infection results in upregulation of plasminogen activator inhibitor-1 and neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity. eJHaem 4:324\u2013338","journal-title":"eJHaem"},{"key":"4191_CR43","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11739-020-02585-9","volume":"16","author":"I Martinelli","year":"2021","unstructured":"Martinelli I, Ciavarella A, Abbattista M et al (2021) Increasing dosages of low-molecular-weight heparin in hospitalized patients with Covid-19. Intern Emerg Med 16:1223\u20131229","journal-title":"Intern Emerg Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04191-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-04191-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-025-04191-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:02:04Z","timestamp":1792789324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-025-04191-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4191"],"URL":"https:\/\/doi.org\/10.1007\/s11739-025-04191-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CN has received honoraria for participating as speaker by Takeda. FB reports grants or contracts from AstraZeneca, Chiesi, GSK, and Insmed; consulting fees from GSK, Menarini, and OM Pharma; payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events from AstraZeneca, Chiesi, GSK, Grifols, Insmed, Menarini, Novartis, Ompharma, Pfizer, Sanofi, Vertex, Viatris, and Zambon. RG has received honoraria for participating as a speaker in educational events organized by Roche and Pfizer and she is member of scientific advisory boards of Bayer and Pfizer. FP has received honoraria for participating as a speaker in education meetings organized by Grifols and Roche, and she is member of scientific advisory boards of Biomarin, Roche, Sanofi, Sobi, and Takeda. The other authors do not have any conflict of interests to disclose relevant to the present manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the 2013 revision of the Declaration of Helsinki and the code of Good Clinical Practice and approved by the local ethic committee of Milano\u2014Area 2 (No. 360_2020).","order":2,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent before any study procedure.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}